Liabooks Home|PRISM News
PRISM

#Made in China 2025

Total 1 articles

The $1B Drug: How China is Engineering the End of Big Pharma's R&D Empire
EconomyEN
The $1B Drug: How China is Engineering the End of Big Pharma's R&D Empire

China is no longer a pharma copycat. With $1B R&D cycles and a massive data advantage, it's building a new global innovation engine. A PRISM analysis for investors.